Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Agnieszka Pawlos"'
Autor:
Ewelina Woźniak, Marlena Broncel, Agnieszka Woźniak, Joanna Satała, Agnieszka Pawlos, Bożena Bukowska, Paulina Gorzelak-Pabiś
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Heterozygous familial hypercholesterolemia (HeFH) is a common autosomal-dominant inherited disorder associated with atherosclerotic cardiovascular disease (ASCVD). HeFH subjects have a higher lipoprotein(a), i.e. Lp(a), concentration than th
Externí odkaz:
https://doaj.org/article/107dcd07ae654cc39806ab8eafdd483e
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background Lipoprotein (a)–Lp(a) has proinflammatory, prothrombotic and proatherogenic properties and may theoretically influence the course of COVID-19. Objectives The aim of the study was to explore whether patients hospitalized due to COVID-19 w
Externí odkaz:
https://doaj.org/article/64d0635f1ccb46bc80c1ff855da0330a
Autor:
Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak, Łukasz Markiewicz, Agnieszka Piastowska-Ciesielska, Paulina Gorzelak-Pabiś
Publikováno v:
Molecules, Vol 28, Iss 3, p 1112 (2023)
SGLT2 (Sodium-glucose Cotransporter-2) inhibitors are newer glucose-lowering drugs with many cardiovascular benefits that are not fully understood yet. Endothelial integrity plays a key role in cardiovascular homeostasis. 25-hydroxycholesterol (25-OH
Externí odkaz:
https://doaj.org/article/f3ca534689f04956b893d40403a6e093
Autor:
Agnieszka Pawlos, Marlena Broncel, Ewelina Wlazłowska, Elżbieta Jabłonowska, Paulina Gorzelak-Pabiś
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244675 (2020)
BackgroundHIV patients are at increased cardiovascular risk while available European cardiovascular recommendations are ambiguous.MethodsRetrospective analysis of 389 HIV-patients was conducted. Cardiovascular risk was determined by D:A:D, Framingham
Externí odkaz:
https://doaj.org/article/40d9c6b6747f46a4bd1483f5c38b19c9
Publikováno v:
Molecules, Vol 26, Iss 23, p 7213 (2021)
Patients with diabetes are at higher risk of cardiovascular diseases and cognitive impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin, Sotagliflozin) are newer hypoglycemic agents with many pleiotropic effects. I
Externí odkaz:
https://doaj.org/article/b4c676d711244ad1a40aa1f918f5f4bd
Autor:
Mateusz Fabiś, Paulina Gorzelak-Pabiś, Joanna Satała, Agnieszka Pawlos, Jarosław Fabiś, Marlena Broncel
Publikováno v:
Polish Archives of Internal Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4f83a473dfdb8711304993ec079b81
https://doi.org/10.20452/pamw.16348
https://doi.org/10.20452/pamw.16348
Publikováno v:
Clinical and experimental pharmacologyphysiologyREFERENCES. 49(8)
Atherosclerosis is associated with a haemostatic imbalance characterized by excessive activation of pro-inflammatory and pro-coagulant pathways. Non-vitamin K antagonists oral anticoagulant (NOACs) may reduce the incidence of cardiovascular events, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed4330580952cb9619f06ee0658ca0a
https://pubmed.ncbi.nlm.nih.gov/35577580
https://pubmed.ncbi.nlm.nih.gov/35577580
Publikováno v:
Molecules, Vol 26, Iss 7213, p 7213 (2021)
Molecules
Molecules
Patients with diabetes are at higher risk of cardiovascular diseases and cognitive impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin, Sotagliflozin) are newer hypoglycemic agents with many pleiotropic effects. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::570eb806ba17b8e0a66b6abbdcc49db5
https://www.mdpi.com/1420-3049/26/23/7213
https://www.mdpi.com/1420-3049/26/23/7213
Autor:
Mateusz Niedzielski, Agnieszka Pawlos, Ewelina Woźniak, Marlena Broncel, Paulina Gorzelak-Pabiś
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4177, p 4177 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
The virus responsible for the current COVID-19 pandemic is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a new virus with high infectivity and moderate mortality. The major clinical manifestation of COVID-19 is interstitial pneumonia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6e38e4416d129274e647eeb7f9a154d
https://pubmed.ncbi.nlm.nih.gov/33920709
https://pubmed.ncbi.nlm.nih.gov/33920709
Autor:
Agnieszka Pawlos, Elżbieta Jabłonowska, Ewelina Wlazłowska, Paulina Gorzelak-Pabiś, Marlena Broncel
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0244675 (2020)
PLoS ONE, Vol 15, Iss 12, p e0244675 (2020)
Background HIV patients are at increased cardiovascular risk while available European cardiovascular recommendations are ambiguous. Methods Retrospective analysis of 389 HIV-patients was conducted. Cardiovascular risk was determined by D:A:D, Framing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3d1334d28bcfe7dc2d97136bc3df64d
http://europepmc.org/articles/PMC7771861
http://europepmc.org/articles/PMC7771861